Author name: euretina

Optimizing Patient Communication Masterclasses Series – Best practices for enhancing patient education In this EURETINA IME masterclasses series on optimizing patient communication, Dr. Jeffrey Heier shares best practices to enhance patient education for better adherence to age-related macular degeneration (AMD) treatments. He covers various patient education strategies, compares monthly versus bi-monthly injection schedules, and highlights […]

Optimizing Patient Communication Masterclasses Series – Keys to patient adherence with injection therapies In this EURETINA IME masterclass series on optimizing patient communication, Dr. Patricio Schlottmann shares strategies to enhance patient compliance with age-related macular degeneration (AMD) treatments. He discusses effective in-office and out-of-clinic education, key considerations for selecting treatment schedules, the role of at-home

Implementing GA Treatments In this section of the EURETINA IME video interview series on dry AMD & GA, Prof. Frank G. Holz and Dr. Arshad Khanani explore emerging complement pathway-targeting treatments for GA. They discuss key aspects, including patient selection, integrating these treatments into the GA patient workflow, and effectively communicating potential side effects. Prof.

Diagnosing and Monitoring dry AMD In this section of the EURETINA IME video interview series on dry AMD & GA, Prof. Frank G. Holz and Dr. Arshad Khanani discuss essential diagnostic modalities for dry AMD, highlighting what to look for to enable an early diagnosis. They explore how to classify the disease stage using established

Understanding the Impact of Dry AMD and GA In this section of the EURETINA IME video interview series on dry AMD & GA, Prof. Frank G. Holz and Dr. Arshad Khanani discuss the prevalence of dry AMD and GA, highlight major risk factors, and stress the profound impact of GA on patients’ quality of life.